Mitsubishi Tanabe Pharma, Daiichi deal

Mitsubishi Tanabe and Daiichi partnered to commercialize Mitsubishi's MT-2412 to treat Type II diabetes. Daiichi will market MT-2412 and both companies will co-promote the compound, which is under rev...